Full Text View
Tabular View
No Study Results Posted
Related Studies
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
This study is ongoing, but not recruiting participants.
Study NCT00060138   Information provided by National Cancer Institute (NCI)
First Received: May 6, 2003   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Hypercalcemia
Metastatic Cancer
Pain
Additional conditions recognized in this trial
Breast Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Breast Diseases
Calcium Metabolism Disorders
Metabolic Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Water-Electrolyte Imbalance
Interventions listed in this trial
monoclonal antibody CAL
zoledronic acid
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
Immunoglobulins
More general drug interventions related to this trial
Bone Density Conservation Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Ireland Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services